| 英文别名： |
1H-Benzimidazole-6-carboxamide,
5-[(4-bromo-2-fluorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-meth
yl-;MEK162 (ARRY-162, ARRY-438162);1H-Benzimidazole-6-carboxamide,
5-[(4-bromo-2-fluorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)...;1H-Benzimidazole-6-carboxamide,5-[(4-bromo-2-fluorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-;5-[(4-Bromo-2-fluorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide;6-(4-bromo-2-fluoroanilino)-7-fluoro-N-(2-hydroxyethoxy)-3-methylbenzimidazole-5-carboxamide;Binimetinib;Binimetinib (MEK-162);Binimetinib (MEK-162, ARRY-162, ARRY-438162);Binimetinib (MEK162, ARRY-162, ARRY-438162);MEK 162;MK-1775;6-(4-bromo-2-fluorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxyethoxy)amide;6-(4-bromo-2-fluorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid-(2-hydroxyethyoxy)amide;ARRY 162;ARRY 438162;ARRY-162;ARRY-162,MEK-162;ARRY-438162;MEK-162;QCR-138;MEK162;181R97MR71;Binimetinib [USAN:INN];Mektovi;Mektovi (TN);MEK162(Binimetinib);Binimetinib (JAN/USAN);MLS006011180;C17H15BrF2N4O3;GTPL7921;binimetinibum |
沪公网安备 
